Tobacco Regulatory Science (R01 Clinical Trial Optional)
ID: 347922Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/347922

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-23-017.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Tobacco Regulatory Science (R01 Clinical Trial Optional)" aimed at advancing research that informs the regulation of tobacco products to protect public health. This initiative invites R01 applications for biomedical and behavioral research projects that align with the regulatory priorities of the FDA's Center for Tobacco Products, focusing on areas such as product composition, toxicity, addiction, and health effects related to tobacco use. Funding is available for up to six grants, with a maximum direct cost of $500,000 per year for a duration of five years, totaling up to $4 million. Interested applicants must submit their proposals by May 2, 2025, and can find additional information and application instructions at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-OD-23-017-Full-Announcement.html
    RFA-OD-23-017.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and FDA, has announced a Notice of Funding Opportunity (NOFO), RFA-OD-23-017, aimed at advancing tobacco regulatory science. This initiative invites applications for R01 research projects focusing on biomedical and behavioral studies that will provide scientific evidence to enhance the regulation of tobacco products in accordance with the FDA's authority under the Family Smoking Prevention and Tobacco Control Act. The objectives include exploring product composition, toxicity, addiction, health effects, and communication strategies concerning tobacco use. Applications must align with specific scientific domains related to tobacco regulation and may address populations at disproportionate risk from tobacco use. Funding is available up to $4 million for six R01 grants, with a direct cost limit of $500,000 per year over a maximum of five years. Key dates include an application start date of September 6, 2023, and a submission deadline of May 2, 2025. Potential applicants are encouraged to review detailed application instructions and ensure compliance with all submission requirements, including the incorporation of data management and sharing plans as per recent NIH policies. The successful proposals will influence FDA regulatory practices to better protect public health.
    Similar Opportunities
    Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), under the Department of Health and Human Services, is offering the Mentored Research Scientist Career Development Award (K01) in Tobacco Regulatory Research. This grant aims to support researchers in conducting studies that inform the U.S. Food and Drug Administration's (FDA) regulations on tobacco products, as mandated by the Family Smoking Prevention and Tobacco Control Act. The program is designed to foster independent research in critical areas such as product composition, toxicity, addiction, and health effects related to tobacco use, emphasizing the importance of tobacco regulatory science. Awardees are expected to commit at least 75% of their professional effort to the project, with NIH providing up to $90,000 per year for salary and research development expenses. Interested applicants must submit their proposals by March 12, 2025, and can find more information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01) to support intensive career development in research related to tobacco regulations. This grant aims to provide funding for projects that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing, in alignment with the FDA's regulatory authority under the Family Smoking Prevention and Tobacco Control Act. Eligible applicants include various higher education institutions and nonprofit organizations, with awards providing up to $90,000 annually for salary and $60,000 for research-related expenses. Interested applicants must submit their proposals by March 12, 2025, and can find additional information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00), aimed at fostering a new generation of independent researchers focused on tobacco regulation under the FDA's jurisdiction. This grant supports postdoctoral researchers in transitioning to independent faculty positions through a two-phase program: the K99 phase provides up to two years of mentored training, while the R00 phase offers up to three years of independent research funding, with a total funding commitment of $750,000 for approximately five awards. Eligible applicants must have no more than four years of postdoctoral experience and are encouraged to align their proposals with FDA scientific domains, addressing critical issues such as product composition, health effects, and marketing influences. Interested candidates should submit their applications by March 12, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00), aimed at fostering a new generation of independent researchers in the field of tobacco regulation. This grant program is designed to support postdoctoral researchers transitioning to independent faculty positions, with a focus on research that informs the regulation of tobacco products as mandated by the Family Smoking Prevention and Tobacco Control Act. The K99 phase provides up to two years of mentored research training, followed by the R00 phase, which offers up to three years of independent research support, targeting areas such as tobacco product composition, health effects, addiction, and the evaluation of FDA regulatory actions. Applications are due periodically, with the next deadlines on November 14, 2023, and March 12, 2025. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for research projects focused on health equity related to tobacco, alcohol, and cannabis policies. This initiative aims to address disparities in exposure and use of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. The funding opportunity will utilize the R01 grant mechanism, which is optional for clinical trials, and is expected to open for applications in February 2025, with a funding ceiling of $499,999. Interested applicants should prepare their proposals in advance, as the NOFO is anticipated to be published in September 2024, and further details, including a pre-application webinar, will be announced following the publication.
    Data Standards for Tobacco Research and Scientific Review Phase 2
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a cooperative agreement opportunity titled "Data Standards for Tobacco Research and Scientific Review Phase 2," aimed at enhancing tobacco research and improving public health outcomes related to tobacco use. The primary objective of this initiative is to develop open, consensus-based data standards for studies on tobacco products, while also promoting education on standardized data usage among federal regulators, the tobacco industry, and global organizations. This funding opportunity, categorized under consumer protection, has an estimated total program funding of $400,000, with two awards expected to be granted. Interested applicants, particularly small businesses, should note that the synopsis is anticipated to be posted on October 1, 2023, with a closing date of December 1, 2023, and projects are expected to commence on May 1, 2024. For further inquiries, applicants can contact Rene A. Vasquez, Grants Management Specialist, at 301-796-3546 or via email at rene.vasquez@fda.hhs.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for pilot and exploratory research projects focused on health equity related to tobacco, alcohol, and cannabis use. The initiative aims to investigate disparities in exposure and usage of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. This funding opportunity will utilize the R21 grant mechanism, which supports early-stage research, and is expected to be published in September 2024, with the first application deadline in March 2025. Interested applicants should prepare their proposals in advance, as the estimated award date is December 1, 2025, and further details, including a pre-application webinar, will be announced following the NOFO publication.
    Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)." This initiative aims to support pilot and preliminary research that prepares for larger-scale trials focused on improving access to and the effectiveness of treatment services for substance use disorders. The funding is intended to facilitate the testing of various intervention approaches and methodologies, ultimately contributing to the development of effective treatment strategies that address health disparities among vulnerable populations. Applicants may receive up to $450,000 over a three-year period, with proposals due by 5:00 PM local time on January 7, 2025. For further information, interested parties can contact the NIH OER Webmaster at grantsinfo@nih.gov or visit the official announcement at http://grants.nih.gov/grants/guide/pa-files/PA-21-180.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) initiative, specifically targeting Tobacco Use Treatment for Cancer Survivors. This initiative aims to fund up to three research projects that will develop and test strategies to enhance the delivery and sustainability of tobacco use treatment services for cancer survivors, utilizing the UG3/UH3 Exploratory/Developmental Cooperative Agreement activity code, which requires clinical trials. The total estimated funding for this opportunity is $2.4 million, with applications expected to be due in late Fall 2024 and awards anticipated by July 1, 2025. Interested applicants are encouraged to prepare by reviewing related materials and attending a pre-application webinar, details of which will be announced following the NOFO publication.
    Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional), a federal grant opportunity aimed at funding research for developing and testing behavioral treatments for substance use and dependence. This initiative seeks to encourage research that tests the efficacy of behavioral interventions, examines mechanisms of behavior change, and optimizes treatment approaches, particularly for individuals with comorbidities and those in drug abuse treatment. The program is crucial for advancing substance abuse treatment and addressing health disparities, with a maximum funding amount of $450,000 available over three years. Interested applicants, including various educational institutions and community organizations, must submit their proposals by March 21, 2025, and can find additional information at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.